In vivo Efficacy of STX213, A Second-Generation Steroid Sulfatase Inhibitor, for Hormone-Dependent Breast Cancer Therapy
Year: 2006
Type: article
Source: Clinical Cancer Research
Institutions: St Mary's Hospital, Imperial College London, University of Bath
Language: English
Subfield: Endocrinology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2128828790
